{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T14:16:59Z","timestamp":1793024219626,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Psoriasis (PSO) is a skin disorder with systemic inflammation and high coronary artery disease risk. A distinct lipid phenotype occurs in psoriasis, which is characterized by high plasma triglycerides (TGs) with typically normal or even low LDL-C. The extent to which cholesterol on LDL subfractions, such as small dense LDL-C (sdLDL-C), are associated with vulnerable coronary plaque characteristics in PSO remains elusive.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A recently developed equation for estimating sdLDL-C from the standard lipid panel was utilized in a PSO cohort (n\u2009=\u2009200) with 4-year follow-up of 75 subjects. Coronary plaque burden was assessed by quantitative coronary computed tomography angiography (CCTA). Multivariate regression analyses were used for establishing associations and prognostic value of estimated sdLDL-C.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Estimated sdLDL-C was positively associated with non-calcified burden (NCB) and fibro-fatty burden (FFB), which remained significant after multivariate adjustment for NCB (\u03b2\u2009=\u20090.37; <jats:italic>P<\/jats:italic>\u2009=\u20090.050) and LDL-C adjustment for FFB (\u03b2\u2009=\u20090.29; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001). Of note, total LDL-C calculated by the Friedewald equation was not able to capture these associations in the study cohort. Moreover, in the regression modelling estimated sdLDL-C was significantly predicting necrotic burden progression over 4 years follow-up (<jats:italic>P<\/jats:italic>\u2009=\u20090.015), whereas LDL-C did not. Finally, small LDL particles (S-LDLP) and small HDL particles (S-HDLP), along with large and medium TG-rich lipoproteins (TRLPs) had the most significant positive correlation with estimated sdLDL-C.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Estimated sdLDL-C has a stronger association than LDL-C with high-risk features of coronary atherosclerotic plaques in psoriasis patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Clinical trial registration<\/jats:title>\n                <jats:p>URL: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.clinicaltrials.gov\">https:\/\/www.clinicaltrials.gov<\/jats:ext-link>. Unique identifiers: NCT01778569<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12944-023-01819-x","type":"journal-article","created":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T05:02:54Z","timestamp":1682571774000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Estimated sdLDL-C for predicting high-risk coronary plaque features in psoriasis: a prospective observational study"],"prefix":"10.1186","volume":"22","author":[{"given":"Alexander V.","family":"Sorokin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiou","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christin G.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Sampson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"O\u2019Hagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Florida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather L.","family":"Teague","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin P.","family":"Playford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus Y.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nehal N.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan T.","family":"Remaley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,27]]},"reference":[{"key":"1819_CR1","doi-asserted-by":"crossref","unstructured":"Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA et al. \/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;73(24):e285-e350.","DOI":"10.1016\/j.jacc.2018.11.003"},{"issue":"8","key":"1819_CR2","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1001\/jamadermatol.2021.2007","volume":"157","author":"AW Armstrong","year":"2021","unstructured":"Armstrong AW, Mehta MD, Schupp CW, Gondo GC, Bell SJ, Griffiths CEM. Psoriasis prevalence in adults in the United States. JAMA Dermatol. 2021;157(8):940\u20136.","journal-title":"JAMA Dermatol"},{"issue":"4","key":"1819_CR3","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.jaad.2017.06.028","volume":"77","author":"A Egeberg","year":"2017","unstructured":"Egeberg A, Skov L, Joshi AA, Mallbris L, Gislason GH, Wu JJ, et al. The relationship between duration of psoriasis, vascular inflammation, and cardiovascular events. J Am Acad Dermatol. 2017;77(4):650\u20136e3.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"1819_CR4","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.jaad.2020.12.044","volume":"84","author":"M Teklu","year":"2021","unstructured":"Teklu M, Zhou W, Kapoor P, Patel N, Dey AK, Sorokin AV, et al. Metabolic syndrome and its factors are associated with noncalcified coronary burden in psoriasis: an observational cohort study. J Am Acad Dermatol. 2021;84(5):1329\u201338.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"1819_CR5","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.atherosclerosis.2012.06.068","volume":"224","author":"NN Mehta","year":"2012","unstructured":"Mehta NN, Li R, Krishnamoorthy P, Yu Y, Farver W, Rodrigues A, et al. Abnormal lipoprotein particles and cholesterol efflux capacity in patients with psoriasis. Atherosclerosis. 2012;224(1):218\u201321.","journal-title":"Atherosclerosis"},{"key":"1819_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1471-5945-12-20","volume":"12","author":"BM Akkara Veetil","year":"2012","unstructured":"Akkara Veetil BM, Matteson EL, Maradit-Kremers H, McEvoy MT, Crowson CS. Trends in lipid profiles in patients with psoriasis: a population-based analysis. BMC Dermatol. 2012;12:20.","journal-title":"BMC Dermatol"},{"issue":"4","key":"1819_CR7","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.jaad.2005.11.1079","volume":"54","author":"L Mallbris","year":"2006","unstructured":"Mallbris L, Granath F, Hamsten A, St\u00e5hle M. Psoriasis is associated with lipid abnormalities at the onset of skin disease. J Am Acad Dermatol. 2006;54(4):614\u201321.","journal-title":"J Am Acad Dermatol"},{"issue":"9738","key":"1819_CR8","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0140-6736(10)60713-1","volume":"376","author":"PM Ridker","year":"2010","unstructured":"Ridker PM, Genest J, Boekholdt SM, Libby P, Gotto AM, Nordestgaard BG, et al. HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial. Lancet. 2010;376(9738):333\u20139.","journal-title":"Lancet"},{"issue":"6","key":"1819_CR9","doi-asserted-by":"publisher","first-page":"53b","DOI":"10.1016\/0002-9149(95)80012-H","volume":"75","author":"RM Krauss","year":"1995","unstructured":"Krauss RM. Dense low density lipoproteins and coronary artery disease. Am J Cardiol. 1995;75(6):53b\u20137b.","journal-title":"Am J Cardiol"},{"issue":"4","key":"1819_CR10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00439-012-1256-1","volume":"132","author":"AC Frazier-Wood","year":"2013","unstructured":"Frazier-Wood AC, Manichaikul A, Aslibekyan S, Borecki IB, Goff DC, Hopkins PN, et al. Genetic variants associated with VLDL, LDL and HDL particle size differ with race\/ethnicity. Hum Genet. 2013;132(4):405\u201313.","journal-title":"Hum Genet"},{"issue":"1","key":"1819_CR11","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1161\/ATVBAHA.113.302401","volume":"34","author":"MY Tsai","year":"2014","unstructured":"Tsai MY, Steffen BT, Guan W, McClelland RL, Warnick R, McConnell J, et al. New automated assay of small dense low-density lipoprotein cholesterol identifies risk of coronary heart disease: the multi-ethnic study of atherosclerosis. Arterioscler Thromb Vasc Biol. 2014;34(1):196\u2013201.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"1819_CR12","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.numecd.2018.06.022","volume":"28","author":"DM Schulte","year":"2018","unstructured":"Schulte DM, Paulsen K, T\u00fcrk K, Brandt B, Freitag-Wolf S, Hagen I, et al. Small dense LDL cholesterol in human subjects with different chronic inflammatory diseases. Nutr Metab Cardiovasc Dis. 2018;28(11):1100\u20135.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"5","key":"1819_CR13","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1161\/ATVBAHA.114.303284","volume":"34","author":"RC Hoogeveen","year":"2014","unstructured":"Hoogeveen RC, Gaubatz JW, Sun W, Dodge RC, Crosby JR, Jiang J, et al. Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. Arterioscler Thromb Vasc Biol. 2014;34(5):1069\u201377.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"1819_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12933-020-01015-6","volume":"19","author":"JL Jin","year":"2020","unstructured":"Jin JL, Zhang HW, Cao YX, Liu HH, Hua Q, Li YF, et al. Association of small dense low-density lipoprotein with cardiovascular outcome in patients with coronary artery disease and diabetes: a prospective, observational cohort study. Cardiovasc Diabetol. 2020;19(1):45.","journal-title":"Cardiovasc Diabetol"},{"key":"1819_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12986-019-0334-y","volume":"16","author":"J Fan","year":"2019","unstructured":"Fan J, Liu Y, Yin S, Chen N, Bai X, Ke Q, et al. Small dense LDL cholesterol is associated with metabolic syndrome traits independently of obesity and inflammation. Nutr Metab (Lond). 2019;16:7.","journal-title":"Nutr Metab (Lond)"},{"issue":"9","key":"1819_CR16","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1053\/meta.2002.34695","volume":"51","author":"H Ohmura","year":"2002","unstructured":"Ohmura H, Mokuno H, Sawano M, Hatsumi C, Mitsugi Y, Watanabe Y, et al. Lipid compositional differences of small, dense low-density lipoprotein particle influence its oxidative susceptibility: possible implication of increased risk of coronary artery disease in subjects with phenotype B. Metabolism. 2002;51(9):1081\u20137.","journal-title":"Metabolism"},{"issue":"8","key":"1819_CR17","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/S0022-2275(20)42610-0","volume":"31","author":"E Hurt-Camejo","year":"1990","unstructured":"Hurt-Camejo E, Camejo G, Rosengren B, Lopez F, Wiklund O, Bondjers G. Differential uptake of proteoglycan-selected subfractions of low density lipoprotein by human macrophages. J Lipid Res. 1990;31(8):1387\u201398.","journal-title":"J Lipid Res"},{"issue":"11","key":"1819_CR18","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1161\/CIRCRESAHA.118.313608","volume":"123","author":"AV Sorokin","year":"2018","unstructured":"Sorokin AV, Kotani K, Elnabawi YA, Dey AK, Sajja AP, Yamada S, et al. Association between Oxidation-Modified lipoproteins and coronary plaque in Psoriasis. Circ Res. 2018;123(11):1244\u201354.","journal-title":"Circ Res"},{"issue":"4","key":"1819_CR19","doi-asserted-by":"publisher","first-page":"319","DOI":"10.5551\/jat.49528","volume":"27","author":"T Izumida","year":"2020","unstructured":"Izumida T, Nakamura Y, Hino Y, Ishikawa S. Combined effect of small dense low-density lipoprotein cholesterol (sdLDL-C) and Remnant-Like particle cholesterol (RLP-C) on Low-Grade inflammation. J Atheroscler Thromb. 2020;27(4):319\u201330.","journal-title":"J Atheroscler Thromb"},{"issue":"7","key":"1819_CR20","doi-asserted-by":"publisher","first-page":"624","DOI":"10.5551\/jat.43968","volume":"26","author":"SH Hsu","year":"2019","unstructured":"Hsu SH, Jang MH, Torng PL, Su TC. Positive Association between small dense low-density lipoprotein cholesterol concentration and biomarkers of inflammation, thrombosis, and Prediabetes in non-diabetic adults. J Atheroscler Thromb. 2019;26(7):624\u201335.","journal-title":"J Atheroscler Thromb"},{"issue":"17","key":"1819_CR21","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1016\/j.jacc.2020.02.059","volume":"75","author":"EK Duran","year":"2020","unstructured":"Duran EK, Aday AW, Cook NR, Buring JE, Ridker PM, Pradhan AD. Triglyceride-rich lipoprotein cholesterol, small dense LDL cholesterol, and Incident Cardiovascular Disease. J Am Coll Cardiol. 2020;75(17):2122\u201335.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"1819_CR22","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.bbalip.2011.09.008","volume":"1821","author":"JD Brunzell","year":"2012","unstructured":"Brunzell JD, Zambon A, Deeb SS. The effect of hepatic lipase on coronary artery disease in humans is influenced by the underlying lipoprotein phenotype. Biochim Biophys Acta. 2012;1821(3):365\u201372.","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"1819_CR23","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1093\/clinchem\/hvab048","volume":"67","author":"M Sampson","year":"2021","unstructured":"Sampson M, Wolska A, Warnick R, Lucero D, Remaley AT. A new equation based on the standard lipid panel for calculating small dense low-density lipoprotein-cholesterol and its use as a risk-enhancer test. Clin Chem. 2021;67(7):987\u201397.","journal-title":"Clin Chem"},{"issue":"8","key":"1819_CR24","doi-asserted-by":"publisher","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","volume":"147","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The strengthening the reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147(8):573\u20137.","journal-title":"Ann Intern Med"},{"issue":"9","key":"1819_CR25","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.jcmg.2016.05.005","volume":"9","author":"RC Cury","year":"2016","unstructured":"Cury RC, Abbara S, Achenbach S, Agatston A, Berman DS, Budoff MJ, et al. Coronary artery Disease - Reporting and Data System (CAD-RADS): an Expert Consensus Document of SCCT, ACR and NASCI: endorsed by the ACC. JACC Cardiovasc Imaging. 2016;9(9):1099\u2013113.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"39","key":"1819_CR26","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1093\/eurheartj\/ehv339","volume":"36","author":"T Salahuddin","year":"2015","unstructured":"Salahuddin T, Natarajan B, Playford MP, Joshi AA, Teague H, Masmoudi Y, et al. Cholesterol efflux capacity in humans with psoriasis is inversely related to non-calcified burden of coronary atherosclerosis. Eur Heart J. 2015;36(39):2662\u20135.","journal-title":"Eur Heart J"},{"issue":"4","key":"1819_CR27","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-T","volume":"15","author":"AS Agatston","year":"1990","unstructured":"Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15(4):827\u201332.","journal-title":"J Am Coll Cardiol"},{"key":"1819_CR28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.clinbiochem.2018.10.011","volume":"64","author":"MK Palmer","year":"2019","unstructured":"Palmer MK, Barter PJ, Lundman P, Nicholls SJ, Toth PP, Karlson BW. Comparing a novel equation for calculating low-density lipoprotein cholesterol with the Friedewald equation: a VOYAGER analysis. Clin Biochem. 2019;64:24\u20139.","journal-title":"Clin Biochem"},{"issue":"5","key":"1819_CR29","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1001\/jamacardio.2020.0013","volume":"5","author":"M Sampson","year":"2020","unstructured":"Sampson M, Ling C, Sun Q, Harb R, Ashmaig M, Warnick R, et al. A New equation for calculation of low-density lipoprotein cholesterol in patients with normolipidemia and\/or hypertriglyceridemia. JAMA Cardiol. 2020;5(5):540\u20138.","journal-title":"JAMA Cardiol"},{"issue":"13","key":"1819_CR30","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.jacc.2021.02.009","volume":"77","author":"MS Garshick","year":"2021","unstructured":"Garshick MS, Ward NL, Krueger JG, Berger JS. Cardiovascular Risk in patients with psoriasis: JACC Review topic of the Week. J Am Coll Cardiol. 2021;77(13):1670\u201380.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"1819_CR31","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jaad.2017.10.050","volume":"78","author":"MT Wan","year":"2018","unstructured":"Wan MT, Shin DB, Hubbard RA, Noe MH, Mehta NN, Gelfand JM. Psoriasis and the risk of diabetes: a prospective population-based cohort study. J Am Acad Dermatol. 2018;78(2):315\u201322e1.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"1819_CR32","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1001\/archdermatol.2010.370","volume":"147","author":"TJ Love","year":"2011","unstructured":"Love TJ, Qureshi AA, Karlson EW, Gelfand JM, Choi HK. Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003\u20132006. Arch Dermatol. 2011;147(4):419\u201324.","journal-title":"Arch Dermatol"},{"issue":"2","key":"1819_CR33","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1161\/01.ATV.21.2.282","volume":"21","author":"M Gu\u00e9rin","year":"2001","unstructured":"Gu\u00e9rin M, Le Goff W, Lassel TS, Van Tol A, Steiner G, Chapman MJ. Atherogenic role of elevated CE transfer from HDL to VLDL(1) and dense LDL in type 2 diabetes: impact of the degree of triglyceridemia. Arterioscler Thromb Vasc Biol. 2001;21(2):282\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"Pt 5","key":"1819_CR34","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1042\/bst0311066","volume":"31","author":"CJ Packard","year":"2003","unstructured":"Packard CJ. Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein. Biochem Soc Trans. 2003;31(Pt 5):1066\u20139.","journal-title":"Biochem Soc Trans"},{"issue":"9","key":"1819_CR35","doi-asserted-by":"publisher","first-page":"e011199","DOI":"10.1161\/CIRCIMAGING.120.011199","volume":"13","author":"H Choi","year":"2020","unstructured":"Choi H, Uceda DE, Dey AK, Abdelrahman KM, Aksentijevich M, Rodante JA, et al. Treatment of Psoriasis with Biologic Therapy is Associated with improvement of coronary artery plaque lipid-rich necrotic core: results from a prospective, observational study. Circ Cardiovasc Imaging. 2020;13(9):e011199.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"1","key":"1819_CR36","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0005-2760(79)90133-4","volume":"575","author":"RW Mahley","year":"1979","unstructured":"Mahley RW, Weisgraber KH, Innerarity TL. Interaction of plasma lipoproteins containing apolipoproteins B and E with heparin and cell surface receptors. Biochim Biophys Acta. 1979;575(1):81\u201391.","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"1819_CR37","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.tips.2015.07.001","volume":"36","author":"GD Norata","year":"2015","unstructured":"Norata GD, Tsimikas S, Pirillo A, Catapano AL. Apolipoprotein C-III: from pathophysiology to Pharmacology. Trends Pharmacol Sci. 2015;36(10):675\u201387.","journal-title":"Trends Pharmacol Sci"},{"issue":"13","key":"1819_CR38","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1161\/CIRCULATIONAHA.117.031276","volume":"137","author":"MK Jensen","year":"2018","unstructured":"Jensen MK, Aroner SA, Mukamal KJ, Furtado JD, Post WS, Tsai MY, et al. High-density lipoprotein subspecies defined by Presence of Apolipoprotein C-III and Incident Coronary Heart Disease in four cohorts. Circulation. 2018;137(13):1364\u201373.","journal-title":"Circulation"},{"key":"1819_CR39","doi-asserted-by":"crossref","unstructured":"Sorokin AV, Patel N, Abdelrahman KM, Ling C, Reimund M, Graziano G et al. Complex association of apolipoprotein E-containing HDL with coronary artery disease burden in cardiovascular disease. JCI Insight. 2022;7(10).","DOI":"10.1172\/jci.insight.159577"},{"issue":"4","key":"1819_CR40","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jacc.2014.11.019","volume":"65","author":"Y Qi","year":"2015","unstructured":"Qi Y, Fan J, Liu J, Wang W, Wang M, Sun J, et al. Cholesterol-overloaded HDL particles are independently associated with progression of carotid atherosclerosis in a cardiovascular disease-free population: a community-based cohort study. J Am Coll Cardiol. 2015;65(4):355\u201363.","journal-title":"J Am Coll Cardiol"},{"key":"1819_CR41","doi-asserted-by":"crossref","unstructured":"Tardif JC, Karwatowska-Prokopczuk E, Amour ES, Ballantyne CM, Shapiro MD, Moriarty PM et al. Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular risk. Eur Heart J. 2022.","DOI":"10.1093\/eurheartj\/ehab820"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-023-01819-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-023-01819-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-023-01819-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T05:05:49Z","timestamp":1682571949000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-023-01819-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,27]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1819"],"URL":"https:\/\/doi.org\/10.1186\/s12944-023-01819-x","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,27]]},"assertion":[{"value":"20 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Study approval was granted by the National Heart, Lung and Blood Institute institutional review board in keeping with the Declaration of Helsinki. All study participants submitted written informed consent prior to enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have seen and agreed to the submitted content of the paper and are accountable for all aspects of the accuracy and integrity of the manuscript in accordance with ICMJE criteria.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflicts of interest with the contents of this article. Dr. Alan T. Remaley is a full-time US Government employee. Dr. Nehal N. Mehta has served as a consultant for Amgen, Eli Lilly, and Leo Pharma receiving grants\/other payments; as a principal investigator and\/or investigator for AbbVie, AstraZeneca, Celgene, Janssen Pharmaceuticals, Inc, and Novartis receiving grants and\/or research funding and as a principal investigator for the National Institutes of Health receiving grants and\/or research funding. All other authors declare no financial disclosures.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}